socalTECH

NOVEMBER 22, 2021

San Diego-based medical visualization software developer LifeVoxel.AI LifeVoxel said it offers up aces to imaging studies and data, allowing for what it calls "4D interactive intelligent medical image views" over the Internet. announced this morning that it has raised $5M in a seed funding round.

Seed Funding 140

Seed Funding San Diego Study Software Development 140

socalTECH

MARCH 28, 2019

San Diego-based biotech startup Biolinq , which is developing wireless-enabled biosensor patches for continuous monitoring of biomarkers, has raised $4.75M additional Series A funding, the company said this morning. The funding came from JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners. READ MORE>>.

Marketing 168

Marketing San Diego Venture Capital Study 168

socalTECH

AUGUST 31, 2021

San Diego-based "ARS Pharmaceuticals, which is developing an epinephrine nasal spray designed to better treat severe allergic reaction, said today that it has raised $55M in a Series D funding. The funding was led by SR One, and also included RA Capital Management, an un-named US healthcare-focused fund, and Deerfield Management.

Funding 113

Funding San Diego Study Design 113

socalTECH

NOVEMBER 9, 2020

San Diego-based Arcturus Therapeutics has received up to $220M in additional financial commitments from the country of Singapore, after receiving positive Phase 1/2 study results on one of its compounds. READ MORE>>.

Arcturus 113

Arcturus Study San Diego Funding 113

socalTECH

APRIL 28, 2017

San Diego-based Epic Sciences has raised $40M in a Series D funding, for its cancer testing technology, the company announced Friday morning. The company said the fund will go to accelerate clinical studies and enhance its technology. Epic sciences is developing blood-based tests which help predict drug response in cancer.

Funding 153

Funding San Diego Study Capital 153

socalTECH

NOVEMBER 7, 2018

San Diego-based Mirium Pharmaceuticals , which is developing treatments for rare liver diseases, announced on Wednesday morning that it has raised $120M in a Series A funding round. The company says it recently had a successful Phase 2b study. READ MORE>>.

San Diego 147

San Diego Study Capital Funding 147

socalTECH

OCTOBER 1, 2018

San Diego-based VelosBio , a biotech startup developing novel antibody-drug conjugates to treat hematological cancers and solid tumours, has raised $58M in a funding round. The Series A funding was led by Arix Bioscience, and also included Pappas Ventures, Chiesi Ventures, Takeda Ventures, and Decheng Capital. READ MORE>>.

San Diego 113

San Diego Study Funding Capital 113

Xconomy

JULY 29, 2020

Thrive Earlier Detection, one of the companies vying to be the first to commercialize a blood test that can uncover cases of cancer before symptoms arise, has raised $257 million and announced plans to evaluate its CancerSEEK test in a registrational study.

San Diego 87

San Diego Study Capital Invest 87

Xconomy

SEPTEMBER 15, 2016

The Connect Innovation Report found that 405 software, technology, and life sciences startups were created last year in San Diego County. Innovation Companies in San Diego (Courtesy Connect Innovation Report).

San Diego 40

San Diego Report High Tech Study 40

Xconomy

JUNE 23, 2020

Reneo Pharmaceuticals has encouraging results from an early trial of a compound it is advancing for rare diseases characterized by impaired mitochondria—our cells’ energy generators—and the company says it is now designing a large global study of its drug candidate.

San Diego 127

San Diego Study Design Develop 127

Xconomy

MAY 19, 2020

Amplyx Pharmaceuticals has completed enrollment in one mid-stage trial of its lead drug candidate, a new kind of antifungal treatment, and has finished treating the first patients in two more such studies.

San Diego 114

San Diego Funding Study Company 114

socalTECH

JUNE 24, 2019

San Diego-based biopharmaceuticals startup AFYX Therapeutics announced this morning that it has raised $13M in a convertible loan financing. The company is currently in an ongoing, Phase 2B study. The note came from Sofinnova Ventuers, which led the investment, and also included Nova Seeds and Lundbeckfonden Emerge.

Study 113

Study San Diego Platform Invest 113

Xconomy

MARCH 28, 2019

million from new investors, including the New York-based Juvenile Diabetes Research Foundation, following the results of a clinical study of its experimental biomarker monitoring device. Founders Jared Tagney and Joshua Windmiller, who met while in grad school at UC San Diego, started the company in 2012 as Electrozyme.

San Diego 103

San Diego Study Research Design 103

socalTECH

JANUARY 5, 2016

San Diego-based Halozyme Therapeutics , the publicly held cancer therapeutics developer, has entered into a $150M credit agreement, the company said this morning. The debt funding comes from Pharmakon Advisors and Athyrium Capital Management. READ MORE>>.

Study 100

Study San Diego Capital Funding 100

socalTECH

SEPTEMBER 12, 2018

San Diego-based Epic Sciences , which is developing technology around personalization of cancer treatment and management, has raised $52M more in a Series E funding, the company's lead investor said this morning. Epic has now raised more than $137.5M RUSNANO, and VI Ventures. READ MORE>>.

Artificial Inteligence 100

Artificial Inteligence San Diego Study Invest 100

Xconomy

NOVEMBER 3, 2017

Klotho Therapeutics , a virtual biotech developing a kidney disease treatment based on its proprietary engineered version of the human klotho enzyme, said Thursday it has raised $10 million in Series A financing from San Diego’s Thynk Capital. Thynk Capital founder and principal Jim Plante also is Klotho’s founder and CEO.

San Diego 85

San Diego Study Capital Technology 85

socalTECH

FEBRUARY 16, 2016

San Diego- and Cambridge, England-based Akarna Therapeutics Ltd. The biopharmaceutials company, whch is working on treatments for non-alcoholic steatohepatitis (NASH), a fatty liver disease, said the funding came from Forbion Capital Partners, New Science Ventures, and Third Point Ventures. The company is led by Dr. Raju Mohan.

San Diego 100

San Diego Study Funding Capital 100

socalTECH

JANUARY 27, 2016

San Diego-based biopharmaceuticals developer Halozyme Therapeutics said yesterday that it has raised $150M in royalty-backed, debt financing. The financing came from Pharmakon Advisors and Athyrium Capital Management. According to the company, the funding will go towards a Phase 3 cancer study in cancer patients.

Funding 100

Funding San Diego Study Capital 100

socalTECH

APRIL 1, 2020

San Diego-based Aspen Neuroscience , a biotechnology company developing treatments for Parkinson disease, said it has raised $70M in a Series A funding round. The funding was led by OrbiMed, and also included ARCH Venture Partners, Frazier Healthcare Partners, Domain Associates, Section 32, and Sam Altman.

San Diego 113

San Diego Screening Study Course 113

socalTECH

JULY 24, 2017

San Diego-based eFFECTOR Therapeutics , a developer of treatments for cancer, has raised $38.6M eFFECTOR said the funding goes towards Phase 2 efforts for eFT508, the company's investigational small molecule MNK1/2 inhibitor, which is currently being studied for treating colerectal cancer. in total funding. READ MORE>>.

Study 113

Study San Diego Invest Funding 113

socalTECH

MAY 9, 2018

San Diego-based Escient Pharmaceuticals announced Wednesday morning that it has raised $40M in a Series A funding, to develop drugs to treat neuro-immuno-inflammatory and autoreactive diseases. The funding came from The Column Group and 5AM Ventures, along with Osage University Partners. READ MORE>>.

San Diego 100

San Diego Study Funding Develop 100

socalTECH

FEBRUARY 13, 2013

San Diego-based DriveCam , the developer of driver monitoring systems for commercial automobile fleets, said this morning that it has received a strategic investment from Volvo Group. According to DriveCam, Volvo Group Venture Capital made the strategic investment, and becomes a minority shareholder in the company.

Invest 153

Invest San Diego Study Venture Capital 153

Xconomy

APRIL 11, 2017

As part of the financing, Kalamazoo-based Octeta Therapeutics has been rechristened Cirius Therapeutics, and three San Diego-based biotech executives are stepping into key executive roles. All three were former Laguna Pharmaceuticals executives who spent the past 16 months scouting for Frazier as entrepreneurs-in-residence.

Study 55

Study San Diego Entrepreneur Venture Capital 55

Xconomy

AUGUST 22, 2019

The San Diego-based company’s experimental drug fosmetpantotenate failed a Phase 3 trial, FORT, in patients with a rare and deadly neurological disorder called pantothenate kinase-associated neurodegeneration, or PKAN.

San Diego 79

San Diego Study Marketing Develop 79

Xconomy

OCTOBER 1, 2018

VelosBio joined Johnson & Johnson’s JLABS @ San Diego incubator in January. The new VelosBio cash is earmarked for completing the work needed to proceed into human studies. The company is developing antibody drug conjugates, a class of cancer drug that links antibodies to potent cancer-fighting toxins.

San Diego 91

San Diego Incubator Class Study 91

Xconomy

APRIL 22, 2019

Swiss pharma giant Novartis has invested $75 million in a $142 million Series C round for San Diego-based Poseida, which is one of several companies developing what is meant to be a one-time, long-lasting treatment for multiple myeloma. Multiple myeloma affects about 300,000 Americans every year.

San Diego 83

San Diego Study Funding Invest 83

SoCal Tech Calendar

OCTOBER 17, 2012

Tuesday, October 23, 2012 -- The San Diego Tech Coast Angels present Early-Stage Valuation. Program Overview: This interactive workshop educates and empowers angel investors, entrepreneurs, and others interested in access to capital on a variety of ways to value pre-revenue companies. Email linda@techcoastangels.com.

Tech Coast Angels 113

Tech Coast Angels Case Study San Diego Study 113

socalTECH

NOVEMBER 11, 2010

San Diego-based Aires Pharmaceuticals , a developer of treatments for pulmonary arterial hypertension, said this morning that it has raised $20M in a Series B funding round. The round was led by MPM Capital, and also included prior investor ProQuest Investments. MPM's Dr. William Greene joins the board as part of the funding.

San Diego 154

San Diego Venture Capital Study Capital 154

socalTECH

JANUARY 4, 2012

San Diego-based Elevation Pharmaceuticals , which is developing treatment for patients with chronic obstructive pulmonary disease (COPD), said this morning that it has closed on a $30M, Series B funding round. The firm said the funds will help the firm complete all activities to reach Phase 3 studies by the end of 2013.

San Diego 133

San Diego Study Activity Funding 133

Xconomy

DECEMBER 20, 2018

New biopharma company Aristea Therapeutics has raised $15 million from Novo Holdings, the Danish investment company, and secured global rights to an investigational AstraZeneca drug that’s ready for Phase 2 study. The San Diego, CA, company made its public debut this week after starting up quietly earlier this year.

Develop 67

Develop Development San Diego Study 67

socalTECH

APRIL 15, 2019

San Diego-based Wheels (www.takewheels.com) was co-founded by Jon and Josh Viner, who were the co-founders of Wag, where they raised nearly $400M in venture capital. Wheels currently operates in Los Angeles and San Diego. Josh Viner: Wheels is live in Los Angeles and San Diego. What is Wheels?

San Diego 113

San Diego Startup Study Los Angeles 113

Xconomy

FEBRUARY 15, 2017

For these reasons, fatty liver disease is often called a “silent disease,” says Ariel Feldstein, a gastroenterologist at the University of California San Diego. Feldstein has been studying the liver for nearly 20 years, and his research now forms the basis of a newly launched company called Jecure Therapeutics.

UCSD 64

UCSD Press San Diego Class 64

socalTECH

NOVEMBER 11, 2010

San Diego-based biopharmaceuticals firm Ceregene announced this morning that it has raised $11.5M The round was co-led by Hamilton Bioventures and Alta Partners, and also included MPM Capital and Investor Growth Capital. Tags: ceregene venture capital lifescience parkinsons disease biopharma. READ MORE>>.

San Diego 124

San Diego Venture Capital Study Capital 124

socalTECH

NOVEMBER 30, 2010

San Diego-based Histogen , a developer of regenerative medicine products, announced today that it has raised $10M in a Series A financing round. Tags: histogen venture capital stem cell lifescience regenerative medicine. READ MORE>>.

San Diego 173

San Diego Study Venture Capital Product 173

socalTECH

DECEMBER 6, 2012

San Diego-based Avelas Biosciences has raised $7.65M in a Series A funding round, which it says will go towards clinical studies for its technology for real-time tumor visualization. The funding came from Avalon Ventures. Avelas is developing technology for visualizing cancerous lymph nodes in breast cancer patients.

Avalon 138

Avalon San Diego Study Technology 138

socalTECH

MAY 25, 2012

San Diego-based biopharmaceuticals firm Sangart has raised $50M in a Series G funding round, the company announced Thursday, bringing its total venture funds raised to $280M. The firm said the funding will go towards advancing development of its medicines, which are currently in Phase 2b studies. READ MORE>>.

San Diego 133

San Diego Study Funding Develop 133

socalTECH

JUNE 23, 2010

San Diego-based Nereus Pharmaceuticals , a firm developing drugs for the treatment of lung cancer, said Tuesday that it has raised another $20M in funding and commitments from its venture backers. Tags: nereus pharmaceuticals lifescience venture capital cancer biotech biopharma biopharmaceuticals.

San Diego 140

San Diego Venture Capital Study Funding 140